Dr. Antje Lindemann

Chief R&D Director of Tanlaer Pharma and Director of Onanich Pharmaceutical R&D Center

Dr. Antje Lindemann, PhD in Biology from Germany, serves as Chief R&D Director of Tanlaer Pharma and Director of Onanich Pharmaceutical R&D Center. She previously conducted cancer research at The University of Texas MD Anderson Cancer Center. Dr. Lindemann has published more than ten high-quality scientific papers in renowned journals and participated in the R&D of dozens of anti-cancer drugs. She has held senior leadership roles including Vice President of Laboratory Operations, Laboratory Manager and Chief Technical Supervisor. She is responsible for high-throughput laboratory operation, quality assurance programs, regulatory inspections and coordination of interdisciplinary teams. During her tenure at Tanlaer Pharma, Dr. Lindemann leads a 9-member R&D team to develop new products targeting anti-aging and cardiovascular diseases, and has achieved major breakthroughs in related research programs.